Trombofilia: Causa 75% de morbidade e mortalidade neonatal - Synlab

Gestational complications resulting from thrombophilia account for about 75% of the causes of neonatal morbidity and mortality.

Published by Synlab on 08 May 2024
Banner Principal Imagem de fundo seção

Thrombophilia is potentiated in pregnancy and puerperium due to the procoagulant characteristics of these conditions.  They can be classified as: acquired and hereditary and affect approximately 15% of the general population.

Gestational complications caused by thrombophilia can be described as placental thrombosis, severe forms of gestational hypertension, premature placental detachment, intrauterine fetal growth restriction, which may progress to fetal death. These complications represent about 75% of the causes of neonatal morbidity and mortality.

The new THROMBOINCODE Genetic evaluation reproductive health, offered by SYNLAB, assesses the risk of venous thromboembolism during pregnancy and the puerperium by analyzing 12 variants in 7 genes associated with thrombophilia. The result is obtained through a mathematical algorithm that makes it possible to assess the patient’s risk in three ways: the patient’s risk of having thrombophilia associated with the current clinical condition (variable factors such as weight, smoking, habits and lifestyle); patient risk compared to the risk of heterozygosity for Factor V Leiden, with the same clinical profile, and the risk with the same clinical profile considering the genetic variants found. Enabling a complete analysis of the genetic implications for the risk of thrombophilia and, in turn, of recurrent pregnancy loss.

 

About the SYNLAB Group

The SYNLAB Group is a leader in providing medical diagnostic services in Europe, providing a full range of clinical laboratory analysis services to patients, healthcare professionals, clinics and the pharmaceutical industry. Resulting from the Labco and SYNLAB merger, the new SYNLAB Group is the undisputed European leader in medical laboratory services.

Find out about the exam Icone Next

Related Posts

08/05/2024

More comprehensive genetic analyses help patients with predisposition to thrombophilia

Genetic profiles that study more variants associated with thromboembolic events…

Continue reading Icon Next
08/05/2024

Gestational Diabetes Mellitus: A near-hidden danger

Genetic testing has revealed greater prospects in the early diagnosis…

Continue reading Icon Next
08/05/2024

Preeclampsia: The combination of factors can predict preeclampsia in up to 76.6% of the cases.

While conventional screening tests can detect only 30% of the…

Continue reading Icon Next

Search our blog

We want to share our news with you!

Stay informed by subscribing to our Newsletter and receive exclusive updates on cutting-edge diagnostic medicine worldwide.

Thank you for signing up to our Newsletter!

This email is already registered!

An error occurred, please try later!

Contact us